MedPath
HSA Approval

CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INJECTION 1G/VIAL

SIN15008P

CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INJECTION 1G/VIAL

CEFTRIAXONE KABI POWDER FOR SOLUTION FOR INJECTION 1G/VIAL

May 20, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DD04

ceftriaxone

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

LABESFAL – Laboratorios Almiro, SA

Active Ingredients

Ceftriaxone Sodium 3.5 H2O 1193mg eqv Ceftriaxone

1000mg/ vial

Ceftriaxone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.